The discrepancy likely stems from the inflammatory milieu associated with sepsis, which acutely increases IL-8, a pro-inflammatory cytokine, unlike the stable pre-chemotherapy conditions of our MM patient cohort. The gene discussed is CXCL8; the disease is Miyoshi myopathy.